190 related articles for article (PubMed ID: 24107156)
21. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
22. Outcome of Stage IV Completely Necrotic Wilms Tumour and Local Stage III Treated According to the SIOP 2001 Protocol.
Dávila Fajardo R; Furtwängler R; van Grotel M; van Tinteren H; Pasqualini C; Pritchard-Jones K; Al-Saadi R; de Camargo B; Ramírez Villar GL; Graf N; Muracciole X; Melchior P; Saunders D; Rübe C; van den Heuvel-Eibrink MM; Janssens GO; Verschuur AC
Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33652659
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of histopathological response to preoperative chemotherapy in unilateral Wilms' tumor: An analysis of 899 patients treated on the SIOP WT 2001 protocol in the UK-CCLG and GPOH studies.
Vujanić GM; D'Hooghe E; Graf N; Vokuhl C; Al-Saadi R; Chowdhury T; Pritchard-Jones K; Furtwängler R
Int J Cancer; 2021 Sep; 149(6):1332-1340. PubMed ID: 34109628
[TBL] [Abstract][Full Text] [Related]
24. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
[TBL] [Abstract][Full Text] [Related]
25. Hepatic metastasis at diagnosis in patients with Wilms tumor is not an independent adverse prognostic factor for stage IV Wilms tumor: a report from the Children's Oncology Group/National Wilms Tumor Study Group.
Ehrlich PF; Ferrer FA; Ritchey ML; Anderson JR; Green DM; Grundy PE; Dome JS; Kalapurakal JA; Perlman EJ; Shamberger RC
Ann Surg; 2009 Oct; 250(4):642-8. PubMed ID: 19730241
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of pediatric nephroblastoma in southern Thailand.
Sangkhathat S; Chotsampancharaen T; Kayasut K; Patrapinyokul S; Chiengkriwate P; Kitichet R; Maipang M
Asian Pac J Cancer Prev; 2008; 9(4):643-7. PubMed ID: 19256753
[TBL] [Abstract][Full Text] [Related]
27. Outcome analysis of stage I epithelial-predominant favorable-histology Wilms tumors: A report from Children's Oncology Group study AREN03B2.
Parsons LN; Mullen EA; Geller JI; Chi YY; Khanna G; Glick RD; Aldrink JH; Vallance KL; Kim Y; Fernandez CV; Dome JS; Perlman EJ
Cancer; 2020 Jun; 126(12):2866-2871. PubMed ID: 32267967
[TBL] [Abstract][Full Text] [Related]
28. Surgical implications for liver metastases in nephroblastoma--data from the SIOP/GPOH study.
Fuchs J; Szavay P; Luithle T; Furtwängler R; Graf N
Surg Oncol; 2008 Jul; 17(1):33-40. PubMed ID: 17935976
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of event-free survival in patients with Wilms tumor undergoing preoperative chemotherapy. Analysis of lymph-node yield in a single-center cohort.
Flores P; Cadario M; Strambach J; Sanjuanelo M; Saleme JM; Paz E; Cacciavillano W; Felizzia G; Galluzzo L; Corbetta JP
J Pediatr Urol; 2021 Apr; 17(2):227.e1-227.e5. PubMed ID: 33309612
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment for bilateral nephroblastomatosis is an independent risk factor for progressive disease in patients with stage V nephroblastoma.
Furtwängler R; Schmolze M; Gräber S; Leuschner I; Amann G; Schenk JP; Niggli F; Kager L; von Schweinitz D; Graf N
Klin Padiatr; 2014 May; 226(3):175-81. PubMed ID: 24819388
[TBL] [Abstract][Full Text] [Related]
31. [The assessment of nephroblastoma therapy results using the SIOP 92-01 protocol].
Madziara W; Bohosiewicz J
Wiad Lek; 1998; 51 Suppl 3():106-9. PubMed ID: 9814117
[TBL] [Abstract][Full Text] [Related]
32. Wilms' tumor in adults: results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study.
Reinhard H; Aliani S; Ruebe C; Stöckle M; Leuschner I; Graf N
J Clin Oncol; 2004 Nov; 22(22):4500-6. PubMed ID: 15542800
[TBL] [Abstract][Full Text] [Related]
33. Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30-year SIOP-RTSG experience.
Vujanić GM; Graf N; D'Hooghe E; Pritchard-Jones K; Bergeron C; Tinteren HV; Furtwängler R;
Pediatr Blood Cancer; 2024 Mar; 71(3):e30852. PubMed ID: 38185745
[TBL] [Abstract][Full Text] [Related]
34. High dose consolidation with autologous stem cell rescue (ASCR) for nephroblastoma initially treated according to the SIOP 9/GPOH trial and study.
Hempel L; Kremens B; Weirich A; Graf N; Zintl F; Ludwig R
Klin Padiatr; 1996; 208(4):186-9. PubMed ID: 8776705
[TBL] [Abstract][Full Text] [Related]
35. Histoclinical study of nephroblastoma in relation to current and previous SIOP Classification of Renal Tumors of Childhood.
Taran K; Sitkiewicz A; Kobos J
Pol J Pathol; 2010; 61(4):234-9. PubMed ID: 21290348
[TBL] [Abstract][Full Text] [Related]
36. [Renal neoplasms in children].
Sawicz-Birkowska K; Czernik J; Bagłaj M; Czauderna P; Kantorowicz-Szymik S; Poznański WA; Mańkowski P; Madziara W; Prokurat A; Osemlak J
Przegl Lek; 2004; 61 Suppl 2():20-3. PubMed ID: 15686041
[TBL] [Abstract][Full Text] [Related]
37. A 23-year experience with malignant renal tumors in infancy and childhood.
Tröbs RB; Hänsel M; Friedrich T; Bennek J
Eur J Pediatr Surg; 2001 Apr; 11(2):92-8. PubMed ID: 11371043
[TBL] [Abstract][Full Text] [Related]
38. Wilms tumor: five-year tumor-free survival on a modified SIOP protocol from an Indian university hospital.
Trehan A; Chowdhary SK; Marwaha RK
J Pediatr Hematol Oncol; 2012 Jan; 34(1):57-62. PubMed ID: 21423048
[TBL] [Abstract][Full Text] [Related]
39. [Organ-sparing surgery for nephroblastoma in children].
Ismail-zade RS; Kochubinskiĭ DV; Shimanskiĭ AT; Nazaruk SI; Rutskaia EA; Begin IV; Fedorova AS; Savva NN; Vydanov OI
Vopr Onkol; 2012; 58(4):502-6. PubMed ID: 23607205
[TBL] [Abstract][Full Text] [Related]
40. Treatment of pulmonary metastases in children with stage IV nephroblastoma with risk-based use of pulmonary radiotherapy.
Verschuur A; Van Tinteren H; Graf N; Bergeron C; Sandstedt B; de Kraker J
J Clin Oncol; 2012 Oct; 30(28):3533-9. PubMed ID: 22927531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
